KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,189,881 | +7.4% | 100,059 | +35.4% | 0.00% | 0.0% |
| Q2 2023 | $2,969,583 | +11.7% | 73,907 | +18.7% | 0.00% | 0.0% |
| Q1 2023 | $2,658,502 | -62.0% | 62,260 | -57.3% | 0.00% | -50.0% |
| Q4 2022 | $7,002,373 | +5.5% | 145,822 | -17.3% | 0.00% | 0.0% |
| Q3 2022 | $6,635,000 | +62.4% | 176,364 | +19.3% | 0.00% | +100.0% |
| Q2 2022 | $4,086,000 | -41.2% | 147,851 | +15.7% | 0.00% | 0.0% |
| Q1 2022 | $6,952,000 | -0.4% | 127,831 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $6,980,000 | +239.8% | 119,298 | +129.8% | 0.00% | – |
| Q3 2021 | $2,054,000 | +115.3% | 51,909 | +131.0% | 0.00% | – |
| Q2 2021 | $954,000 | +143.4% | 22,470 | +253.2% | 0.00% | – |
| Q1 2021 | $392,000 | -95.5% | 6,362 | -94.9% | 0.00% | -100.0% |
| Q4 2020 | $8,741,000 | +1179.8% | 123,915 | +599.4% | 0.00% | – |
| Q3 2020 | $683,000 | – | 17,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |